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Bacterial artificial chromosomes (BACs) are powerful tools for the manipulation of
the large genomes of DNA viruses, such as herpesviruses. However, the methods
currently used to construct the recombinant viruses, an important intermediate link in
the generation of BACs, involve the laborious process of multiple plaque purifications.
Moreover, some fastidious viruses may be lost or damaged during these processes,
making it impossible to generate BACs from these large-genome DNA viruses. Here, we
introduce the CRISPR/Cas9 as a site-specific gene knock-in instrument that promotes
the homologs recombination of a linearized transfer vector and the Pseudorabies
virus genome through double incisions. The efficiency of recombination is as high as
86%. To our knowledge, this is the highest efficiency ever reported for Pseudorabies
virus recombination. We also demonstrate that the positions and distances of the
CRISPR/Cas9 single guide RNAs from the homology arms correlate with the efficiency
of homologous recombination. Our work show a simple and fast cloning method of
BACs with large genome inserted by greatly enhancing the HR efficiencies through
CRISPR/Cas9-mediated homology-directed repair mechanism, and this method could
be of helpful for manipulating large DNA viruses, and will provide a successful model for
insertion of large DNA fragments into other viruses.
Keywords: CRISPR/Cas9, homologous recombination, bacterial artificial chromosome, pseudorabies virus,
knock-in
INTRODUCTION
Pseudorabies virus (PRV), the causative agent of Aujeszky’s disease, is a member of the family
Herpesviridae, the subfamily Alphaherpesvirinae, and the genus Varicellovirus (Matthews, 1982).
PRV can infect most mammals, except humans and other higher primates, but pigs are the only
known natural reservoir (Klupp et al., 1995). Because it is a neurotropic pathogen, effectively
invading the peripheral nervous system and establishing a lifelong latent infection in the neurons
resident in the peripheral ganglia (Smith, 2012), it is an important model to analyze the virus
transportation mechanism in the nerve system. A PRV variant emerged in China in 2011 that
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caused typical neurological symptoms and high mortality
in newborn piglets on many farms, resulting in substantial
economic losses (An et al., 2013).
Bacterial artificial chromosomes (BACs) are especially useful
platforms for studying herpesviruses because the genomes of
these viruses are too large to be cloned into plasmids or
cosmids (Wagner et al., 2002). Since the first generation of
BACs containing mutant murine cytomegalovirus (Messerle
et al., 1997), a variety of BACs containing different viruses
have been generated, including human cytomegalovirus using
homologous recombination (HR) (Borst et al., 1999), varicella
zoster virus with overlapping cosmid inserts (Tischer et al.,
2007), Human herpesvirus 6A using the direct ligation method
(Borenstein and Frenkel, 2009), and herpesvirus using in vitro
transposition (Zhou et al., 2009). A herpesvirus genome is
normally cloned into a BAC with HR between the viral
genome and the flanking DNA fragments of the BAC cassette
(Adler et al., 2003). Because the efficiency of HR is low, the
recombinant virus have to subject to multiple rounds of plaque
purification, which is labor intensive and time consuming,
especially for some slow-growing viruses. More importantly,
for some fastidious viruses that fail to produce plaques in
cells, such as Kaposi’s sarcoma-associated herpesvirus, it can be
impossible to isolate the purified recombinant virus (Zhou et al.,
2002).
The efficacy of HR can be significantly improved by DNA
double-stranded breaks (DSBs) (Gao et al., 2016). DSBs have
been shown to stimulate cell repair pathways, including error-
prone nonhomologs end joining (Bibikova et al., 2003) and
homology-directed repair (Urnov et al., 2005). Homology-
directed repair can precisely repair the damaged DNA in the
presence of homologous donor DNA, whereas nonhomologs
end joining is an error-prone mechanism that always results in
a heterogeneous pool of insertions and deletions (Ran et al.,
2013). CRISPR/Cas9 is emerging as a powerful tool for DNA
engineering in diverse organisms, and allows efficient DNA
editing (Cong et al., 2013). Gene knock-in of large DNA viruses
with CRISPR/Cas9 has been reported, including of adenovirus
(Bi et al., 2014), Herpes simplex virus 1 (Bi et al., 2014),
PRV (Xu et al., 2015; Liang et al., 2016; Tang et al., 2016),
and Epstein–Barr virus (Kanda et al., 2016). However, there
is little information about the features of CRISPR/Cas9 that
are important in enhancing the efficiency of the HR between
PRV and BAC. In this study, we systematically studied the
correlation between the location of single guide RNA (sgRNA)
and the efficacy of HR in the construction of a BAC encoding
PRV.
MATERIALS AND METHODS
Virus and Cell Line
The PRV-HLJ8 strain (GenBank accession no. KT824771)
isolated in 2014 was replicated. Vero cells were cultured in
Dulbecco’s modified Eagle’s medium (Gibco, Grand Island, NY,
USA). All culture media were supplemented with 10% heat-
inactivated fetal bovine serum (Gibco Life Technologies).
Generation and Linearization of the
Transfer Vector pBAC-GFP62
The plasmid pBeloBAC11 vector (New England
Biolabs) was first inserted into two loxP sites
(ATAACTTCGTATAATGTATGCTATACGAAGTTAT) to
generate pBeloBACloxP. The green fluorescence protein (GFP)
cassette was cut from the pEFGP-N1 vector (Clontech) with
BamHI and HindIII restriction enzymes and inserted into the
pBACloxp11 vector, generating pBAC-GFP. The upstream
homologous arm (including the entire US6 gene and partial US4
gene, 1695 bp) and the downstream homologous arm (including
the partial US2 gene and partial US1 gene, 1547 bp) were
amplified with PCR. They were then inserted into pBAC-GFP,
constructing the transfer vector pBAC-GFP62 (Us4-Us6, position
−10648 to −8946 bp; Us2-Us1, position 402 to 1957 bp). After
pBAC-GFP62 was confirmed with enzymatic digestion and DNA
sequencing, the plasmid was linearized with SwaI and purified
with the QIAEX II Gel Extraction Kit (Qiagen). The primers
used are described in Table 1.
Cotransfection and Plaque Purification
Assay
The PRV HLJ genome was extracted as previously described
(Szpara et al., 2011). For all cotransfections, 3µg of the PRV
HLJ genome and 3µg of linearized pBAC-GFP62 were added
to each individual well. For control group, 2µg of pCas9 vector
(pX330) was cotranfected; for single incision group, each was
cotransfected with 1µg of pCas9-sgRNA and 1µg of pCas9
vector, respectively; for double-incision group, each individual
well was cotransfected with 2µg of pCas9-sgRNAs (two pCas9-
sgRNAs, each 1µg). To all the solutions was added 16µL of
X-tremeGENE HP DNA Transfection Reagent (Roche, Basel,
Switzerland), according to the manufacturer’s instructions. After
72 h, the cells were collected and subjected to three freeze–
thaw cycles. The recombinant virus BAC-HLJ (vBAC-HLJ) was
purified with plaque purification in Vero cells overlain with
1% low-melting-point agarose and Dulbecco’s modified Eagle’s
medium containing 2% fetal bovine serum. After seven rounds
of purification, all the plaques expressed GFP, were detected with
fluorescence microscopy.
Electrotransformation Assay
The replicative intermediate (covalently closed circular) PRV
HLJ DNA was isolated as previously described (Hirt, 1967).
Escherichia coliDH10B cells were electroporated with the circular
genome of PRV (2.5 kV, 200, 25µF; Bio-Rad) (Mahony et al.,
2002), and the cells were then incubated in 1 mL of SOC
medium for 1 h at 37◦C with shaking at 220 rpm. The medium
was centrifuged, plated on Luria–Bertani (LB) plates containing
17µg/mL chloramphenicol, and incubated for 24 h at 37◦C.
Chloramphenicol-resistant colonies were inoculated into 5mL of
LB broth containing 17 µg/mL chloramphenicol and grown at
37◦C for 16 h.
Identification of pBAC-HLJ with PCR
To confirm the integrity of the PRV HLJ genome inserted
into the BAC, genes spread throughout the pBAC-HLJ
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TABLE 1 | Sequences of PCR primers and sgRNA oligonucleotides.
Fragments Name Sequences (5′–3′) Length (bp)
Us4-Us6 Us4F CTGATTTAAATTTCGTCTCGCCCTCTGACATC 1695
Us6R CTGTTAATTAACCCCCTCAGGCGGAAGAAGAT
Us2-Us1 Us2F TGCATCGATCATCACCACCGAGACGCACGA 1547
Us1R CCGATTTAAATGGACGGGGACGACTTTGACGG
CMV-GFP CMV-GFP-F TATGGATCCTGATCGATCGATTTAAATCGTTAATTAATAGTTATTAATAGTAATCAATTAC 1500
CMV-GFP-R CGCAAGCTTACATTGATGAGTTTGGACAAACCAC
gB gB-F GTCACCTTGTGGTTGTTG 180
gB-R CCACATCTACTACAAGAACG
gC gC-F TCTCGGTGGCCGTCAAGGG 740
gC-R GCGGACCTCGAAGGTCTCCC
gG gG-F ACCGCTACGACACCAAGGTC 706
gG-R GCCGCCGTCAAAGAACCAG
gH gH-F AGCTCCAGGACACCCTCTTCGG 730
gH-R GGGCGCTGCACAAAGTACCAC
gK gK-F GCACGTCCCACAGGTAGGCG 498
gK-R CCCGACTGGGTGCTCTTCC
gN gN-F TACAATCGCCTGCACCTCGC 765
gN-R AGGAGCCGTGGCCATCGTAG
gI gI-F TGCTGAACGCCAGCGTCGTGT 150
gI-R GCCGGGCCACGCAGGCGATCC
gE gE-F CATCTGGCTCTGCGTGCTGTGCTCC 367
gE-R GGTCACGCCATAGTTGGGTCCATTCGT
sgRNA-Us7 sgRNA-Us7-R CACCGGTCGGGGGCGTCCTCTTCAG
sgRNA-Us7-F AAACCTGAAGAGGACGCCCCCGACC
sgRNA-Us8 sgRNA-Us8-R CACCGGGGCAGGAACGTCCAGATCC
sgRNA-Us8-F AAACGGATCTGGACGTTCCTGCCCC
sgRNA-Us9 sgRNA-Us9-F CACCGCGACGTCCTGCTGGCCCCCA
sgRNA-Us9-R AAACTGGGGGCCAGCAGGACGTCGC
sgRNA-Us2 sgRNA-Us2-F CACCGACCGTGGTCACGCTGATGGA
sgRNA-Us2-R AAACTCCATCAGCGTGACCACGGTC
genome were detected with PCR, including the partial BAC
sequence, GFP in the transfer vector pBAC-GFP62, and
essential genes in the PRV genome: gB, gC, gG, gH, gK, and
gN. The genes deleted from pBAC-HLJ, gE and gI, were
also identified in the parental virus, PRV HLJ, as a positive
control.
Pulse-Field Gel Electrophoresis (PFGE)
The DNA (5µg) of wild-type PRV HLJ, the pBAC-HLJ plasmid,
or rescue virus BAC-HLJ (resBAC-HLJ) was digested with
BamHI for 3 h at 37◦C. The three samples were analyzed with
PFGE, with an upper limit of 60 kb and a lower limit 1 kb, with a
previously reported method (Han et al., 2013).
Electron Microscopy
Vero cells were infected with resBAC-HLJ and harvested at
48 h postinfection (hpi), after three rounds of freeze–thaw. Cell
culture medium containing resBAC-HLJ was first centrifuged at
3000 g for 10 min, and then the supernatant was centrifuged
at 10,000 g for 10min. The sample was negatively stained with
2% phosphotungstic acid, and the morphology of the viral
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particles was examined with transmission electron microscope
(Hitachi).
Replication Kinetics of Rescued vBAC-HLJ
Vero cells were infected with PRV HLJ and resBAC-HLJ at 103
50% tissue culture infective doses (TCID50), and were harvested
at 12, 24, 36, 48, 60, and 72 hpi. After the inoculated cells
were freeze thawed three times, the cellular supernatants were
collected and serially diluted 10-fold from 10−1 to 10−9. Vero
cells in 96-well plates were infected with 0.1mL/well of serially
diluted cell supernatant, in sextuple. Five days after infection,
TCID50 was determined with the Reed–Muenchmethod. All data
are shown as the means of three independent experiments.
CRISPR/Cas9 sgRNA Incision Efficacy
Assay
The sgRNAs efficacies were evaluated as described by Tang
et al. (2016). In brief, different sgRNAs of CRISPR/Cas9 were
constructed and then were transfected into Vero cells. Twelve
hours post-transfection, cells were infected with 0.01 MOI of
Luciferase Tagged PRV. Twelve hours post infection, luciferase
activity was evaluated.
HR Efficiency Assay
The cell inoculums were collected 72 h after cotransfection,
and subjected to three freeze–thaw cycles. The numbers of
recombinant viruses were calculated by counting the GFP-
stained colonies under an inverted fluorescence microscope
and counting the total viruses with a crystal violet assay. The
efficiency of HR was determined from the plaque assay as the
ratio of recombinant viruses to total viruses.
Statistical Analysis
The data were analyzed with one-way analysis of variance
followed by Tukey’s multiple comparison test. P-values of 0.05
or less were considered statistically significant.
RESULTS
Generation of BAC of PRV
A graphical abstract of the experiment was illustrated (Figure S1),
to have a clear knowledge of the procedures to generate pBAC-
HLJ. First the transfer vector pBAC-GFP62 was constructed
(Figure 1A). After pBAC-GFP62 was confirmed with enzymatic
digestion and DNA sequencing, the plasmid was linearized and
purified. Vero cells were cotransfected with pBAC-GFP62 and
the extracted PRV HLJ genome DNA (Szpara et al., 2011), and
the HR efficiency of the group adding additional 2µg pCas9
vector was regarded as the control. An equal amount of pCas9-
Us8 was added to the plasmid and PRV HLJ genome, together
with the transfection reagent, to enhance the HR efficiency. At
72 h post-transfection, the HR efficiencies of the control and
the Us8 were calculated. The HR efficiency of CRISPR/Cas9
was higher than that of the control. After recombinant viruses
displaying GFP fluorescence were detected, seven rounds of
plaque purifications were performed, and the pure recombinant
virus was identified by testing for glycoprotein E (gE, Us8) and
gI (Us7) with PCR. The vBAC-HLJ was propagated and the
circular intermediates were isolated with Hirt extraction (Hirt,
1967). Escherichia coli strain DH10B was electroporated with the
circular viral genome, as described previously (Mahony et al.,
2002), and chloramphenicol-resistant clones were assayed for the
successful replication of pBAC-HLJ.
After pBAC-HLJ was confirmed with PCR (Figure S2), it was
used to transfect Vero cells to rescue the virus. The pBAC-HLJ-
transfected cells were checked for a cytopathic effect (CPE) and
green (GFP) fluorescence (Figures 1B,D). The Vero cells without
pBAC-HLJ transfected were detected as controls (Figures 1C,E).
We observed the resBAC-HLJ particles with electronmicroscopy,
and their morphology, with an apparently external envelope, is
shown in Figure 1F.
The replication kinetics of resBAC-HLJ were determined,
using PRV HLJ as the control. The one-step growth curve
indicated that the replication of resBAC-HLJ was lower than that
of wild-type PRVHLJ (Figure 1G). The genome of BAC-HLJ was
extracted (Szpara et al., 2011), digested, analyzed with PFGE, and
compared with the genome of the parental virus PRV HLJ and
pBAC-HLJ. The sizes of resBAC-HLJ and pBAC-HLJ were similar
to that of PRV HLJ, and any slight differences were attributable
to the substitution of genes Us7–Us8–Us9 into pBAC-GFP62
(Figure 1H).
CRISPR/Cas9 Enhances HR Efficiency
Different CRISPR/Cas9s were used in single-incision
CRISPR/Cas9 or double-incision CRISPR/Cas9 reactions to
determine how the efficiency of HR is affected. For the single
incisions, pCas9-Us2, pCas9-Us7, pCas9-Us8, and pCas9-
Us9 were tested. For the double incisions, the combinations
pCas9-Us7/pCas9-Us9 and pCas9-Us7/pCas9-Us8 were tested.
At 72 hpi, the cells were harvested and subjected to three
freeze–thaw cycles. The HR efficiencies were determined
as the ratios of recombinant viral plaques to total viral
plaques.
The sequences and locations of the sgRNAs of pCas9-Us7,
pCas9-Us8, pCas9-Us9, and pCas9-Us2 are shown in Figure 2A,
and their incision positions are also indicated (Figure 2A),
which were usually at the start sites of their open reading
frames. To determine the incision efficiency of pCas9-Us8, the
plaque number was calculated and compared with the control
(Figure 2B). For the other CRISPR/Cas9s, including pCas9-
Us7, pCas9-Us9, and pCas9-Us2, their incision efficiencies were
determined from the luminescent signals of PRV expressing
firefly luciferase (Figure 2C). A lower percentage luminescent
signal relative to the control signal indicated higher incision
efficiency. The incision efficiency was higher for pCas9-Us2 than
for pCas9-Us7 or pCas9-Us9.
The HR efficiencies of the single incisions are shown
in Figure 2D. Different CRISPR/Cas9s produced different
HR efficiencies. PCas9-Us8 enhanced the HR efficiency by
39%, pCas9-Us2 by 14%, and pCas9-Us7 and pCas9-Us9 by
around 5%. For the double incisions, the combinations pCas9-
Us7/pCas9-Us9 and pCas9-Us7/pCas9-Us8 (Figure 2E) had HR
efficiencies >50%, and the former was as high as 86%. With
an HR efficiency of 86%, several rounds of plaque purification,
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FIGURE 1 | Construction and identification of PRV BAC. (A) Construction of the recombinant virus and insertion of the pBAC-GFP62 vector into the viral genome
are illustrated. The genome of PRV HLJ is illustrated at the top, with a portion of the right end of the genome expanded to show the Us4, Us6, Us7, Us8, Us9, Us2,
and Us1 genes. All recombinants were used to transfect Vero cells. Electrotransformation of the circular BAC-HLJ genome yielded the full-length clone pBAC-HLJ.
(B–E) resBAC-HLJ identification. (B,D) show the CPE and GFP of resBAC-HLJ; (C,E) show the control. Bar: 100 µm. (F) Scanning electron microscopy. Viral
particles with apparent PRV morphology were detected. (G) Replication kinetics of resBAC-HLJ compared with those of wild-type PRV HLJ. Vero cells in six-well
plates were infected with 1000 TCID50 of either PRV HLJ or resBAC-HLJ. The culture supernatants were recovered at 12, 24, 36, 48, 60, and 72 hpi, and TCID50
was determined for each. Titrations were performed in triplicate; error bars represent standard errors of the mean. (H) BamHI digestion. Pulse-field gel electrophoresis
(PFGE) assay established the restriction enzyme profiles of PRV HLJ, pBAC-HLJ, and resBAC-HLJ in 1% agarose. DNA fragments were stained with ethidium
bromide and photographed. *P < 0.05, **P < 0.01.
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FIGURE 2 | HR efficiencies were enhanced by CRISPR/Cas9 incision. (A) Sequences of different CRISPR/Cas9 sgRNAs, their locations, and their incision
positions are shown. (B) pCas9-Us8 incision efficiency was determined by comparing the PRV plaque numbers with the control numbers. (C) Percentage of
fluorescent signals for pCas9-Us2, pCas9-Us7, and pCas9-Us9 are shown by luciferase, which replaced the gene of Us8, indicating the incision efficiencies of those
pCas9-sgRNAs. (D) HR efficiencies of Cas9 single incisions; pCas9-Us8 was up to 39%. (E) HR efficiencies of Cas9 double incisions. HR efficiencies of combinations
pCas9-Us7/pCas9-Us9, pCas9-Us7/pCas9-Us9, and pCas9-Us7/pCas9-Us8 were all >50%, and that of pCas9-Us7/pCas9-Us9 was as high as 86%. (F) Ratios of
HR efficiency to incision efficiency for single incisions. pCas9-Us8 had the highest ratio, pCas9-Us7 and pCas9-Us9 had similar lower ratios, and pCas9-Us2 had the
lowest ratio. The data show that when the incision efficiencies were equal, pCas9-Us8 had the highest HR efficiency. *P < 0.05, **P < 0.01.
which are labor intensive and time consuming, can be avoided
and the inoculum can be used directly in some future research.
Although different single incisions had different HR
efficiencies, their incision efficiencies also varied. The ratios of
HR efficiency to incision efficiency were determined to identify
any effect of the positions of the sgRNAs (Figure 2F). PCas9-Us8
had the highest ratio; those of pCas-Us7 and pCas9-Us9 were
lower and almost the same; and that of pCas9-Us2 was lowest.
These results indicate that single incisions with the same incision
efficiency will show more efficient HR if the incision site is
adjacent to the center of the homology arms.
DISCUSSION
The pBAC-HLJ was rapidly constructed by applying
CRISPR/Cas9 promoting HR. Apart from constructing pBAC-
HLJ, another PRV virus Bartha was also subcloned into a BAC
with the same transfer vector pBAC-GFP62, named pBAC-
Bartha. While Bartha is a vaccine virus, which have Us8/Us9
and partial Us2 genes deleted, it is unachievable to incite these
genes and we can only access to pCas-Us7. Compared to the
control group, we find higher HR efficiency by the application
of pCas9-Us7 (unpublished data), and this once again prove the
availability of CRISPR/Cas9 as efficient knock-in tool. As double
incisions of sgRNAs by CRISPR/Cas9 promote HR greatly with a
linearized donor plasmid, it not only save us much time to purify
a recombinant virus, but it is also possible for us to subclone
the PRV isolates into BAC vector directly, which provide us the
chance of studying herpesvirual versatility.
The HR efficiencies of the double incisions were higher than
those of the single incisions. The combination of pCas9-Us7
and pCas9-Us9 induced HR efficiency as high as 86%. HR
efficacy may be influenced by several factors. In this study, the
incision efficiencies of the CRISPR/Cas9s were first identified
(Tang et al., 2016), and we demonstrated that the positions of
the CRISPR/Cas9 sgRNAs and their distances from the homology
arms correlated with HR efficacy. For single incisions, pCas9-
Us6 was also applied, but showed a lower HR efficiency even
than the control group (almost one-third of the control group,
unpublished data), since it not only incised PRVHLJ genome, but
also incised the transfer vector pBAC-GFP62, we strongly suggest
the target sites should be avoided that both incise the plasmid and
genome for higher efficiency. For other sgRNAs of CRISPR/Cas9
within homology arms of single incision, we inferred that the
closer the incision site is to the center of the homology arms,
the higher is the HR efficiency, and this result is consistent
with the effects of Cas9-mediated nicks on HR efficiency (Ran
et al., 2013). Double incisions have been done by pCas9-
Us6/pCas9-Us2 (unpublished data), pCas9-Us7/pCas9-Us9 and
pCas9-Us7/pCas9-Us8. Of the viruses without GFP, we found
150 viruses in average in 10−3 dilution by pCas9-Us7/pCas9-Us8,
and 13 viruses in average in 10−3 dilution by pCas9-Us7/pCas9-
Us9, and we failed to detect any virus (including the recombinant
virus and wild type virus) by pCas9-Us6/pCas9-Us2 even in 10−1
dilution, which we suppose that the larger the distances between
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two incision sites, the harder the virus to be recovered by NHEJ.
A similar work has been done by Tang et al, who acquired the
recombinant virus almost 100% with genes Us7/Us8/Us9 deleted
by pCas9-Us7 and pCas9-Us2 (unpublished data), which again
support the speculation that more damage are induced by double
incisions with longer distances between them. A comparison of
HR efficiencies by pCas9-Us7/pCas9-Us9 and pCas9-Us7/pCas9-
Us8 showed that while incision sites are within homology arms,
the more two incision sites near the homology arms, the higher
the HR efficiency would be. For us, the best choice of promoting
HR is by double incisions and that the two incision sites near and
within the homology arms but pCas9 gRNAs do not incise them.
In this study, we showed that the combination of linearized
donor plasmid and double incisions of CRISPR/Cas9 that
achieved best HR in PRV. Double incisions are more efficient
than single incision, we suppose double incised viruses are less
easily to be recovered by NHEJ, in which it may replicates faster
than the recombinant virus and dilutes the recombinant virus.
While a circular donor plasmid Tang-Luc-EGFP-HR vector (Tang
et al., 2016) was co-transfected with PRV genome and by single
incision of pCas9-Us8 as well as double incisions of pCas9-Us7
and pCas9-Us9 at the same amount, the single incision and
double incisions both reach an HR efficiency of 0.38 percent. We
suppose the reasonmay be the formation of superhelix of circular
donor plasmid, and thus difficult to be incised by CRISPR/Cas9.
However, in the recent construction of an Epstein–Barr virus-
BAC system, only a circular donor plasmid, rather than a
linearized one, produced successful HR though without exact
HR efficiency (Kanda et al., 2016). Another study in which the
PRV genome was manipulated with CRISPR/Cas9 showed that
HR failed when a linearized homologous repair donor plasmid
was inserted into the PRV genome, but achieved a recombinant
efficiency of almost 50% when a homology-independent DNA
repair mechanism was used (Liang et al., 2016). The different
results generated with linearized donor plasmids and circular
donor plasmids and the efficiencies of HR and nonhomologs
recombination must be explored further.
We also think the length of homology arms will influence
the HR efficiency. As paper published by Li et al, they conclude
that increasing the homology arm sizes enhanced HR efficiency
(Li et al., 2014). Beumer showed us that a comparison of
different homology arm sizes induced different HR efficiencies,
and the length of ∼2 and ∼4 kb have higher efficiencies than
length of 1 or 0.5 kb homology arms, which might provide us
a relationship between the length of homology arms and HR
efficiencies (Beumer et al., 2013). So from our perspective, we
decide the homology arms of ∼1.5 to ∼2 kb are better to induce
high HR.
While we suppose that different cell lines may be varied in
response to the incisions of CRISPR/Cas9 and leading to different
HR efficiencies, further research need to be done to explore the
differences and the relative mechanism. For different viruses,
though we have only tested the CRISPR/Cas9 in PRV, many
papers published online already show that the CRISPR/Cas9 have
ability and high efficiency in both knocking in and knocking
out different viruses (such as HSV, EBV, HIV). Future research
will be directed toward unraveling the other factors affecting HR
efficiency mediated by CRISPR/Cas9, the precise mechanisms
that enhance HR efficiency, and the application of CRISPR/Cas9
to other viruses. This will, in turn, widen our knowledge of
CRISPR/Cas9 as an efficient gene knock-in tool and clarify the
potential of CRISPR/Cas9 in promoting HR as a specialized
instrument. Though the CRISPR/Cas9 is efficient in knocking-
in genes, it still has limitations. While mutations in essential
genes may lead to death of the virus, the CRISPR/Cas9 can
only be applied to insert genes in nonessential parts of the
genome, which is a drawback shared by other technologies
promoting HR.
CONCLUSIONS
Wehave demonstrated that BAC construction with large-genome
viruses can be achieved in a simple rapid way with highly efficient
CRISPR/Cas9-mediated HR. HR efficiency is enhanced when
CRISPR/Cas9 is performed with a linearized donor plasmid,
and the positions of the incisions and their distance from the
homologous arms affect the efficiency of HR. Double incisions
produce higher HR efficiency than single incisions, and we
achieved a HR efficiency by up to 86%, the highest ever reported
for PRV recombination.
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